Larotreni ( Larotrectinib）25mg

Larotreni contains the active substance larotrectinib. Itis used in adults,adolescents and children to treat solid tumours (cancer) in various parts of the body that are caused by a change in the NTRKgene ineurotrophic tyrosine receptor kinase),Larotreni is only used when -these cancers are advanced or have spread to other parts of the body or if a surgeryto remove the cancer is likely to cause severe complicationsand -there are no satisfactory treatment options.Before you are given Larotreni, your doctor will do a test to checkif you have the change in the NTRK gene.